Extracorporeal ultrafiltration for heart failure: focus on organ cross talk and clinical trials.

[1]  A. Santoro,et al.  Continuous ultrafiltration for congestive heart failure: the CUORE trial. , 2014, Journal of cardiac failure.

[2]  C. Ronco,et al.  Ultrafiltration therapy for acute decompensated heart failure: lessons learned from 2 major trials. , 2013, American heart journal.

[3]  K. Anstrom,et al.  Ultrafiltration in decompensated heart failure with cardiorenal syndrome. , 2012, The New England journal of medicine.

[4]  R. Starling,et al.  Cardiorenal outcomes after slow continuous ultrafiltration therapy in refractory patients with advanced decompensated heart failure. , 2012, Journal of the American College of Cardiology.

[5]  S. Werns.  Diuretic Strategies in Patients with Acute Decompensated Heart Failure , 2012 .

[6]  F. van Lente,et al.  Extracorporeal ultrafiltration vs. conventional diuretic therapy in advanced decompensated heart failure. , 2012, Congestive heart failure.

[7]  Adrian F Hernandez,et al.  Diuretic strategies in patients with acute decompensated heart failure. , 2011, The New England journal of medicine.

[8]  G. Gensini,et al.  Effects of ULTRAfiltration vs. DIureticS on clinical, biohumoral and haemodynamic variables in patients with deCOmpensated heart failure: the ULTRADISCO study , 2011, European journal of heart failure.

[9]  D. Mozaffarian,et al.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association. , 2011, Circulation.

[10]  S. Kimmel,et al.  Characteristics of patients with improvement or worsening in renal function during treatment of acute decompensated heart failure. , 2010, The American journal of cardiology.

[11]  Adrian F. Hernandez,et al.  Combination of loop diuretics with thiazide-type diuretics in heart failure. , 2010, Journal of the American College of Cardiology.

[12]  A. Kazory.  Ultrafiltration does not affect certain predictors of outcome in heart failure. , 2010, International journal of cardiology.

[13]  Minoru Horie,et al.  Serum Cortisol as a Useful Predictor of Cardiac Events in Patients With Chronic Heart Failure: The Impact of Oxidative Stress , 2009, Circulation. Heart failure.

[14]  A. Kazory,et al.  Ultrafiltration for decompensated heart failure: renal implications , 2009, Heart.

[15]  Gary S Francis,et al.  Importance of venous congestion for worsening of renal function in advanced decompensated heart failure. , 2009, Journal of the American College of Cardiology.

[16]  M. Gheorghiade,et al.  Acute heart failure syndromes , 2009, Journal of the American College of Cardiology.

[17]  William T. Abraham,et al.  Focused Update : ACCF / AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults , 2013 .

[18]  R. Summers,et al.  Pathophysiology of acute decompensated heart failure. , 2009, Heart failure clinics.

[19]  W. Peacock,et al.  Impact of Intravenous Loop Diuretics on Outcomes of Patients Hospitalized with Acute Decompensated Heart Failure: Insights from the ADHERE Registry , 2008, Cardiology.

[20]  V. Hasselblad,et al.  Cardiorenal interactions: insights from the ESCAPE trial. , 2008, Journal of the American College of Cardiology.

[21]  S. Gottlieb,et al.  A randomized, controlled trial of the renal effects of ultrafiltration as compared to furosemide in patients with acute decompensated heart failure. , 2008, Journal of cardiac failure.

[22]  S. Werns.  Ultrafiltration Versus Intravenous Diuretics for Patients Hospitalized for Acute Decompensated Heart Failure , 2008 .

[23]  D. J. Veldhuisen,et al.  Decreased cardiac output, venous congestion and the association with renal impairment in patients with cardiac dysfunction , 2007, European journal of heart failure.

[24]  G. Fonarow,et al.  Relation of loop diuretic dose to mortality in advanced heart failure. , 2006, The American journal of cardiology.

[25]  A. Boyle,et al.  Ultrafiltration versus usual care for hospitalized patients with heart failure: the Relief for Acutely Fluid-Overloaded Patients With Decompensated Congestive Heart Failure (RAPID-CHF) trial. , 2005, Journal of the American College of Cardiology.

[26]  W. Peacock,et al.  368 Impact of intravenous diuretics on the outcomes of patients hospitalized with acute decompensated heart failure: insights from the ADHERE® Registry , 2004 .

[27]  Christopher M O'Connor,et al.  Effects of tolvaptan, a vasopressin antagonist, in patients hospitalized with worsening heart failure: a randomized controlled trial. , 2004, JAMA.

[28]  K. Weber,et al.  Aldosterone in Congestive Heart Failure , 2004 .

[29]  Z. Vered,et al.  Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes. , 2003, The American journal of cardiology.

[30]  W. Abraham,et al.  Peripherally inserted veno-venous ultrafiltration for rapid treatment of volume overloaded patients. , 2003, Journal of cardiac failure.

[31]  P. Agostoni,et al.  Circulatory response to fluid overload removal by extracorporeal ultrafiltration in refractory congestive heart failure. , 2001, Journal of the American College of Cardiology.

[32]  M. Guazzi,et al.  Cardiac and Renal Dysfunction in Chronic Heart Failure: Relation to Neurohumoral Activation and Prognosis , 2001, The American journal of the medical sciences.

[33]  G. Fonarow,et al.  Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure. , 2000, American heart journal.

[34]  M. Guazzi,et al.  Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure. , 2000, Journal of the American College of Cardiology.

[35]  K. Klouche,et al.  Slow continuous and daily ultrafiltration for refractory congestive heart failure. , 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[36]  F. Russel,et al.  Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. , 1996, Journal of the American College of Cardiology.

[37]  P. Agostoni,et al.  Lung-heart interaction as a substrate for the improvement in exercise capacity after body fluid volume depletion in moderate congestive heart failure. , 1995, The American journal of cardiology.

[38]  M. Guazzi,et al.  Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result. , 1994, The American journal of medicine.

[39]  P. Barbier,et al.  Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure: pathophysiological correlates. , 1993, British heart journal.

[40]  P. Agostoni,et al.  Isolated ultrafiltration in moderate congestive heart failure. , 1993, Journal of the American College of Cardiology.

[41]  M. Guazzi,et al.  Interrelation of humoral factors, hemodynamics, and fluid and salt metabolism in congestive heart failure: effects of extracorporeal ultrafiltration. , 1993, The American journal of medicine.

[42]  M. Guazzi,et al.  Changes in circulating norepinephrine with hemofiltration in advanced congestive heart failure. , 1990, The American journal of cardiology.

[43]  J. Butler,et al.  The heart is not always in good hands. , 1990, Chest.

[44]  C. Cipolla,et al.  Hemofiltration as short-term treatment for refractory congestive heart failure. , 1987, The American journal of medicine.

[45]  C. Ronco,et al.  Continuous Arteriovenous Hemofiltration in the Critically Ill Patient: Clinical Use and Operational Characteristics , 1983 .

[46]  L. Henderson,et al.  Treatment of severe fluid overload by ultrafiltration. , 1974, The New England journal of medicine.

[47]  W. Kolff,et al.  Reduction of otherwise intractable edema by dialysis or filtration. , 1954, Cleveland Clinic quarterly.